866-997-4948(US-Canada Toll Free)

United States Human Vaccine Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 109 Pages

In this report, the United States Human Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Human Vaccine in these regions, from 2012 to 2022 (forecast).

United States Human Vaccine market competition by top manufacturers/players, with Human Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
China National Biotec Group
Hualan Bio
Zhifei
Sinovac
Walvax
Liaoning Chengda
Neptunus Group
GSK
Merck
Novartis
Pfizer
Sanofi
AstraZeneca
Johnson & Johnson
Bavarian Nordic
CSL
Emergent Biosolutions
Unilab

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Inactivated
Attenuated
Toxoid
Subunit
Conjugate
Experimental
Valence
Heterotypic
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Human Vaccine for each application, including
Preventive
Therapeutic

Table of Contents

United States Human Vaccine Market Report 2017
1 Human Vaccine Overview
1.1 Product Overview and Scope of Human Vaccine
1.2 Classification of Human Vaccine by Product Category
1.2.1 United States Human Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Human Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Inactivated
1.2.4 Attenuated
1.2.5 Toxoid
1.2.6 Subunit
1.2.7 Conjugate
1.2.8 Experimental
1.2.9 Valence
1.2.10 Heterotypic
1.3 United States Human Vaccine Market by Application/End Users
1.3.1 United States Human Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Preventive
1.3.3 Therapeutic
1.4 United States Human Vaccine Market by Region
1.4.1 United States Human Vaccine Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Human Vaccine Status and Prospect (2012-2022)
1.4.3 Southwest Human Vaccine Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Human Vaccine Status and Prospect (2012-2022)
1.4.5 New England Human Vaccine Status and Prospect (2012-2022)
1.4.6 The South Human Vaccine Status and Prospect (2012-2022)
1.4.7 The Midwest Human Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Human Vaccine (2012-2022)
1.5.1 United States Human Vaccine Sales and Growth Rate (2012-2022)
1.5.2 United States Human Vaccine Revenue and Growth Rate (2012-2022)

2 United States Human Vaccine Market Competition by Players/Suppliers
2.1 United States Human Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Human Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Human Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Human Vaccine Market Competitive Situation and Trends
2.4.1 United States Human Vaccine Market Concentration Rate
2.4.2 United States Human Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Human Vaccine Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Human Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Human Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Human Vaccine Price by Region (2012-2017)

4 United States Human Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Human Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Human Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Human Vaccine Price by Type (2012-2017)
4.4 United States Human Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Human Vaccine Sales (Volume) by Application (2012-2017)
5.1 United States Human Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Human Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Human Vaccine Players/Suppliers Profiles and Sales Data
6.1 China National Biotec Group
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Human Vaccine Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 China National Biotec Group Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Hualan Bio
6.2.2 Human Vaccine Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Hualan Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Zhifei
6.3.2 Human Vaccine Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Zhifei Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sinovac
6.4.2 Human Vaccine Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sinovac Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Walvax
6.5.2 Human Vaccine Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Walvax Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Liaoning Chengda
6.6.2 Human Vaccine Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Liaoning Chengda Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Neptunus Group
6.7.2 Human Vaccine Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Neptunus Group Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 GSK
6.8.2 Human Vaccine Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 GSK Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Merck
6.9.2 Human Vaccine Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Novartis
6.10.2 Human Vaccine Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novartis Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Pfizer
6.12 Sanofi
6.13 AstraZeneca
6.14 Johnson & Johnson
6.15 Bavarian Nordic
6.16 CSL
6.17 Emergent Biosolutions
6.18 Unilab

7 Human Vaccine Manufacturing Cost Analysis
7.1 Human Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Human Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Human Vaccine Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Human Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Human Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Human Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Human Vaccine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Human Vaccine
Figure United States Human Vaccine Market Size (K Pcs) by Type (2012-2022)
Figure United States Human Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Inactivated Product Picture
Figure Attenuated Product Picture
Figure Toxoid Product Picture
Figure Subunit Product Picture
Figure Conjugate Product Picture
Figure Experimental Product Picture
Figure Valence Product Picture
Figure Heterotypic Product Picture
Figure United States Human Vaccine Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Human Vaccine by Application in 2016
Figure Preventive Examples
Figure Therapeutic Examples
Figure United States Human Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Vaccine Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Human Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Human Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Human Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Human Vaccine Sales Share by Players/Suppliers
Figure United States Human Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Human Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Human Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Human Vaccine Revenue Share by Players/Suppliers
Table United States Market Human Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Human Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Human Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Human Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Vaccine Product Category
Table United States Human Vaccine Sales (K Pcs) by Region (2012-2017)
Table United States Human Vaccine Sales Share by Region (2012-2017)
Figure United States Human Vaccine Sales Share by Region (2012-2017)
Figure United States Human Vaccine Sales Market Share by Region in 2016
Table United States Human Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Human Vaccine Revenue Share by Region (2012-2017)
Figure United States Human Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Human Vaccine Revenue Market Share by Region in 2016
Table United States Human Vaccine Price (USD/Pcs) by Region (2012-2017)
Table United States Human Vaccine Sales (K Pcs) by Type (2012-2017)
Table United States Human Vaccine Sales Share by Type (2012-2017)
Figure United States Human Vaccine Sales Share by Type (2012-2017)
Figure United States Human Vaccine Sales Market Share by Type in 2016
Table United States Human Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Human Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Vaccine by Type (2012-2017)
Figure Revenue Market Share of Human Vaccine by Type in 2016
Table United States Human Vaccine Price (USD/Pcs) by Types (2012-2017)
Figure United States Human Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Human Vaccine Sales (K Pcs) by Application (2012-2017)
Table United States Human Vaccine Sales Market Share by Application (2012-2017)
Figure United States Human Vaccine Sales Market Share by Application (2012-2017)
Figure United States Human Vaccine Sales Market Share by Application in 2016
Table United States Human Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Human Vaccine Sales Growth Rate by Application (2012-2017)
Table China National Biotec Group Basic Information List
Table China National Biotec Group Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure China National Biotec Group Human Vaccine Sales Growth Rate (2012-2017)
Figure China National Biotec Group Human Vaccine Sales Market Share in United States (2012-2017)
Figure China National Biotec Group Human Vaccine Revenue Market Share in United States (2012-2017)
Table Hualan Bio Basic Information List
Table Hualan Bio Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hualan Bio Human Vaccine Sales Growth Rate (2012-2017)
Figure Hualan Bio Human Vaccine Sales Market Share in United States (2012-2017)
Figure Hualan Bio Human Vaccine Revenue Market Share in United States (2012-2017)
Table Zhifei Basic Information List
Table Zhifei Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Zhifei Human Vaccine Sales Growth Rate (2012-2017)
Figure Zhifei Human Vaccine Sales Market Share in United States (2012-2017)
Figure Zhifei Human Vaccine Revenue Market Share in United States (2012-2017)
Table Sinovac Basic Information List
Table Sinovac Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sinovac Human Vaccine Sales Growth Rate (2012-2017)
Figure Sinovac Human Vaccine Sales Market Share in United States (2012-2017)
Figure Sinovac Human Vaccine Revenue Market Share in United States (2012-2017)
Table Walvax Basic Information List
Table Walvax Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Walvax Human Vaccine Sales Growth Rate (2012-2017)
Figure Walvax Human Vaccine Sales Market Share in United States (2012-2017)
Figure Walvax Human Vaccine Revenue Market Share in United States (2012-2017)
Table Liaoning Chengda Basic Information List
Table Liaoning Chengda Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Liaoning Chengda Human Vaccine Sales Growth Rate (2012-2017)
Figure Liaoning Chengda Human Vaccine Sales Market Share in United States (2012-2017)
Figure Liaoning Chengda Human Vaccine Revenue Market Share in United States (2012-2017)
Table Neptunus Group Basic Information List
Table Neptunus Group Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Neptunus Group Human Vaccine Sales Growth Rate (2012-2017)
Figure Neptunus Group Human Vaccine Sales Market Share in United States (2012-2017)
Figure Neptunus Group Human Vaccine Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Human Vaccine Sales Growth Rate (2012-2017)
Figure GSK Human Vaccine Sales Market Share in United States (2012-2017)
Figure GSK Human Vaccine Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Human Vaccine Sales Growth Rate (2012-2017)
Figure Merck Human Vaccine Sales Market Share in United States (2012-2017)
Figure Merck Human Vaccine Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Human Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Human Vaccine Sales Growth Rate (2012-2017)
Figure Novartis Human Vaccine Sales Market Share in United States (2012-2017)
Figure Novartis Human Vaccine Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Sanofi Basic Information List
Table AstraZeneca Basic Information List
Table Johnson & Johnson Basic Information List
Table Bavarian Nordic Basic Information List
Table CSL Basic Information List
Table Emergent Biosolutions Basic Information List
Table Unilab Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Vaccine
Figure Manufacturing Process Analysis of Human Vaccine
Figure Human Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Human Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Human Vaccine
Table Distributors/Traders List
Figure United States Human Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Human Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Human Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Human Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Human Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Human Vaccine Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Human Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Human Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Human Vaccine Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Human Vaccine Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Human Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *